PS
XENT

Portfolio Solutions’s Intersect ENT, Inc XENT Stock Holding History

Portfolio Solutions’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-295
Closed -$12K – 188
2018
Q1 		$12K Hold
295
– – ﹤0.01% 116
2017
Q4 		$10K Hold
295
– – ﹤0.01% 121
2017
Q3 		$9K Sell
295
-85
-22% -$2.52K ﹤0.01% 125
2017
Q2 		$11K Sell
380
-210
-36% -$4.75K ﹤0.01% 107
2017
Q1 		$10K Buy
+590
New +$8.26K ﹤0.01% 132

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Portfolio Solutions's XENT Position: Q2 2018 in Review

Portfolio Solutions sold out of Intersect ENT, Inc (XENT) in Q2 2018, closing a stake of 295 shares — an estimated $12K sold.

Portfolio Solutions first reported a position in XENT in Q1 2017 and held it in 5 quarters. The position peaked at $12K in Q1 2018. 160 funds tracked by Wall St. Rank hold XENT as of Q2 2018.

  • Portfolio Solutions reported no remaining Intersect ENT, Inc position as of Q2 2018 after selling out during the quarter.
  • Portfolio Solutions sold 295 Intersect ENT, Inc shares in Q2 2018, an estimated $12K.
  • Portfolio Solutions first reported a position in Intersect ENT, Inc in Q1 2017 and held it in 5 quarters.
  • Portfolio Solutions's Intersect ENT, Inc position peaked at $12K in Q1 2018.
  • 160 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2018.

Based on Portfolio Solutions's 13F filing for Q2 2018, filed 13 Jul 2018.